Ledger.Open graph →
SEC Form D · Amendment · filed September 13, 2024

Nexo Therapeutics, Inc

Offering
$60.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LITTLETON, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Ali Behbahani · Littleton, CODirectorMichael Kim · Littleton, COExecAndrew Phillips · Littleton, COExec · DirectorCarlo Rizzuto · Littleton, CODirectorDavid Perez · Solana Beach, CAExecSteven Pennock · Scottsdale, AZDirectorCharles I. Smith · Little Rock, ARDirectorScott Carita · Wilmington, DEExec · DirectorJohn Dorsey · Scottsdale, AZExecWalter Raquet · Warba, MNDirectorManish Thakur · New York, NYExec · DirectorRichard A. Smith, Jr · Manhattan Beach, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗